
Microbiology Culture Media
Reliable media and reagents for accurate microbial growth and analysis.
- Dehydrated Culture Media & Bases
- Ready-to-Use Solutions
- Stains & Analytical Reagents
- Antimicrobial Susceptibility Discs
- Accessories

Empowering diagnostics with high-quality RT-PCR kits, nucleic acid extraction systems, and core lab essentials — designed for accuracy, compliance, and scalability.

Kanta Biotech Private Limited, established in 2023 in Goa, is shaping the future of biotechnology in India. With a 7000 m² advanced facility under development — including cleanrooms, QC labs, and warehousing — we are positioned to deliver scalable and reliable solutions for diagnostics, pharmaceuticals, and food industries.
By combining cutting-edge technology with affordability, we create opportunities for laboratories and global partners to access trusted reagents and culture media designed for consistent performance and compliance with international standards.

We aspire to be a globally trusted partner in diagnostics and microbiological solutions, recognized worldwide for our commitment to quality, customer satisfaction, and sustainability. Through innovation and excellence, we deliver high-quality, compliant, and affordable solutions — from RT-PCR diagnostics to nucleic acid extraction systems and culture media — driving growth, innovation, and a healthier, safer future for all.

Reliable media and reagents for accurate microbial growth and analysis.

Advanced diagnostic tools and systems for precise genetic and infectious disease testing.
Since its establishment, Kanta Biotech has been focused on building a strong foundation in diagnostics and microbiology. From developing state-of-the-art facilities to forming international collaborations, every milestone reflects our commitment to innovation and global standards.
Company established in Panaji, Goa, laying the foundation for innovative biotech solutions in diagnostics and microbiology.
Facility development completed, product portfolio finalized, and discussions with leading Russian partners initiated.
Start of microbiology culture media production; regulatory compliance achieved; joint venture with Russian/CIS companies.

